GIM
Gold Investment Management Portfolio holdings
AUM
$266M
This Quarter Return
+0.31%
1 Year Return
+20.42%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
(-4.4%)
Cap. Flow
-$7.05M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
27.89%
Holding
217
New
1
Increased
33
Reduced
92
Closed
1
Top Buys
| 1 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
$2.8M |
| 2 |
Canadian Natural Resources
CNQ
|
$1.79M |
| 3 |
NVIDIA
NVDA
|
$275K |
| 4 |
Brookfield Renewable
BEP
|
$39.8K |
| 5 |
Suncor Energy
SU
|
$27.9K |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$2.87M |
| 2 |
Brookfield Infrastructure Partners
BIP
|
$778K |
| 3 |
Manulife Financial
MFC
|
$698K |
| 4 |
Canadian Pacific Kansas City
CP
|
$682K |
| 5 |
Fortis
FTS
|
$437K |
Sector Composition
| 1 | Financials | 24.66% |
| 2 | Industrials | 15.12% |
| 3 | Technology | 14.84% |
| 4 | Healthcare | 7.68% |
| 5 | Energy | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vanguard Global ex-US Real Estate ETF
VNQI
$3.55B
| $1.62K | ﹤0.01% |
40
+1
| +3% | +$41 |
|
202
CGI
GIB
$21.7B
| $1.6K | ﹤0.01% |
16
| – | – |
|
203
AstraZeneca
AZN
$248B
| $1.56K | ﹤0.01% |
20
| – | – |
|
204
Sanofi
SNY
$121B
| $1.46K | ﹤0.01% |
30
| – | – |
|
205
Unilever
UL
$155B
| $1.38K | ﹤0.01% |
25
| – | – |
|
206
Qorvo
QRVO
$8.4B
| $1.16K | ﹤0.01% |
10
| – | – |
|
207
Novartis
NVS
$245B
| $1.07K | ﹤0.01% |
10
| – | – |
|
208
VanEck Semiconductor ETF
SMH
$27B
| $1.04K | ﹤0.01% |
4
| – | – |
|
209
Vanguard Industrials ETF
VIS
$6.14B
| $941 | ﹤0.01% |
4
| – | – |
|
210
NextEra Energy, Inc.
NEE
$148B
| $921 | ﹤0.01% |
13
| – | – |
|
211
Freeport-McMoran
FCX
$63.7B
| $875 | ﹤0.01% |
18
| – | – |
|
212
Rio Tinto
RIO
$102B
| $791 | ﹤0.01% |
12
| – | – |
|
213
Intel
INTC
$107B
| $155 | ﹤0.01% |
5
| – | – |
|
214
AMC Entertainment Holdings
AMC
$1.44B
| $75 | ﹤0.01% |
15
| – | – |
|
|
ACB
215
Aurora Cannabis
ACB
$305M
| $32 | ﹤0.01% |
7
| – | – |
|
216
Apyx Medical
APYX
$75.3M
| – | – |
-500
| Closed | -$680 |
|
217
Altria Group
MO
$113B
| – | – |
0
| – | – |
|